Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Cue Biopharma (CUE) Return on Equity (2018 - 2025)

Cue Biopharma (CUE) has disclosed Return on Equity for 8 consecutive years, with 0.24% as the latest value for Q4 2025.

  • Quarterly Return on Equity rose 8.0% to 0.24% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.24% through Dec 2025, up 8.0% year-over-year, with the annual reading at 0.24% for FY2025, 2.0% up from the prior year.
  • Return on Equity hit 0.24% in Q4 2025 for Cue Biopharma, up from 0.28% in the prior quarter.
  • In the past five years, Return on Equity ranged from a high of 0.24% in Q4 2025 to a low of 1.85% in Q3 2024.
  • Historically, Return on Equity has averaged 0.85% across 5 years, with a median of 0.74% in 2022.
  • Biggest five-year swings in Return on Equity: tumbled -76bps in 2024 and later skyrocketed 157bps in 2025.
  • Year by year, Return on Equity stood at 0.68% in 2021, then plummeted by -34bps to 0.9% in 2022, then crashed by -37bps to 1.24% in 2023, then surged by 74bps to 0.32% in 2024, then increased by 26bps to 0.24% in 2025.
  • Business Quant data shows Return on Equity for CUE at 0.24% in Q4 2025, 0.28% in Q3 2025, and 0.44% in Q2 2025.